XUZHOU, China, May 27, 2025 /PRNewswire/ — The 7th XCMG International Customer Festival was held in Xuzhou, China, at XCMG’s state-of-the-art intelligent excavator manufacturing hub. The event highlighted next-generation smart, application-specific, and eco-conscious solutions through product showcases, hands-on demonstrations, and collaborative technical exchanges. Industry partners and customers from across the globe gathered to explore the latest… Continue reading Solid Innovation for Green Tomorrow! XCMG Excavator Hosts 7th International Customer Festival in Xuzhou
Tag: People
Global Times: Xi’s reply letter to founder of Danish Chamber of Commerce in China inspires renewed commitment to deeper engagement with Chinese market
BEIJING, May 27, 2025 /PRNewswire/ — “China is a very important market for European businesses. We are confident in this market in the long-term and will continue our commitment to it, serving as a bridge between China and Denmark, and China and Europe,” said Simon Lichtenberg, All China Founding Chairman of the Danish Chamber of Commerce… Continue reading Global Times: Xi’s reply letter to founder of Danish Chamber of Commerce in China inspires renewed commitment to deeper engagement with Chinese market
Solid Innovation for Green Tomorrow! XCMG Excavator Hosts 7th International Customer Festival in Xuzhou
XUZHOU, China, May 27, 2025 /PRNewswire/ — The 7th XCMG International Customer Festival was held in Xuzhou, China, at XCMG’s state-of-the-art intelligent excavator manufacturing hub. The event highlighted next-generation smart, application-specific, and eco-conscious solutions through product showcases, hands-on demonstrations, and collaborative technical exchanges. Industry partners and customers from across the globe gathered to explore the latest… Continue reading Solid Innovation for Green Tomorrow! XCMG Excavator Hosts 7th International Customer Festival in Xuzhou
Infosys und E.ON gehen strategische Partnerschaft ein und treiben die digitale Transformation des Arbeitsplatzes gemeinsam voran
Infosys und E.ON gestalten die digitale Arbeitsumgebung von über 77 000 Mitarbeitenden europaweit effizienter und intuitiver BENGALURU, Indien, 27. Mai 2025 /PRNewswire/ — Infosys (NSE: INFY) (BSE: INFY) (NYSE: INFY), ein weltweit führender Anbieter von digitalen Services und Beratung der nächsten Generation, und E.ON, eines der größten Energieunternehmen Europas in den Bereichen Energienetze, Energieinfrastrukturlösungen und Vertrieb, transformieren… Continue reading Infosys und E.ON gehen strategische Partnerschaft ein und treiben die digitale Transformation des Arbeitsplatzes gemeinsam voran
IBTA Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – IBTA
LOS ANGELES, May 27, 2025 /PRNewswire/ — The DJS Law Group announces that it is investigating claims on behalf of investors of Ibotta, Inc. (“Ibotta” or “the Company”) (NYSE: IBTA) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to… Continue reading IBTA Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – IBTA
MCA, Sebi discuss probe into Gensol Engineering
The corporate affairs ministry (MCA) also launched a separate probe into Gensol and 18 related entities, including EV cab service provider BluSmart Mobility. New Delhi: Securities and Exchange Board of India (Sebi) chairman Tuhin Kanta Pandey has met corporate affairs secretary Deepti Gaur Mukerjee to discuss ongoing investigations into Gensol Engineering, among other regulatory matters,… Continue reading MCA, Sebi discuss probe into Gensol Engineering
Saab’s Capital Markets Day 2025: Well-positioned for future growth
STOCKHOLM, May 27, 2025 /PRNewswire/ — At its Capital Markets Day today in Karlskoga, Sweden, Saab presents an update on its strategic priorities and progress towards capturing future growth and ensuring delivery on customer commitments. This will be achieved through continued capacity expansion, investments in digital transformation and accelerated future capabilities. Follow the presentations live today… Continue reading Saab’s Capital Markets Day 2025: Well-positioned for future growth
United Health Group Incorporated Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – UNH
LOS ANGELES, May 27, 2025 /PRNewswire/ — The DJS Law Group announces that it is investigating claims on behalf of investors of UnitedHealth Group Incorporated (“UnitedHealth” or “the Company”) (NYSE: UNH) for violations of the securities laws. INVESTIGATION DETAILS: The investigation focuses on whether the Company issued false and/or misleading statements and/or failed to disclose information pertinent to… Continue reading United Health Group Incorporated Investigated for Securities Fraud Violations – Contact the DJS Law Group to Discuss Your Rights – UNH
Bio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
GUANGZHOU, China and LONDON, May 27, 2025 /PRNewswire/ — Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STARJEMZA® (ustekinumab-hmny) Injection, a… Continue reading Bio-Thera Solutions and Hikma Pharmaceuticals Announce FDA Approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection
GUANGZHOU, China and LONDON, May 27, 2025 /PRNewswire/ — Bio-Thera Solutions, Ltd (688177:SH), a commercial-stage biopharmaceutical company developing a pipeline of biosimilars and innovative assets and Hikma Pharmaceuticals PLC, along with its wholly owned subsidiary Hikma Pharmaceuticals USA Inc. today announced that the U.S. Food and Drug Administration (FDA) has approved STARJEMZA® (ustekinumab-hmny) Injection, a… Continue reading Bio-Thera Solutions and Hikma Pharmaceuticals announce FDA approval of STARJEMZA® (ustekinumab-hmny) Injection, a biosimilar referencing STELARA® (ustekinumab) Injection